Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

287

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

287 results for “opioid use disorder”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder

ClinicalTrials.gov study NCT04084392. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care

ClinicalTrials.gov study NCT05160233. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov40/100

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

ClinicalTrials.gov study NCT03407638. IPD Sharing: YES. Countries: 1. Publications: 7.

controlledIPD-YESFeb 2026View details →
dryad36/100

Deidentified public survey data for: Patterns and perceptions of nicotine use among U.S. adolescents and young adults receiving medication treatment for opioid use disorder

<p>Nicotine use among U.S. youth is cause for concern, as previous studies have shown that nicotine use in adolescence increases the risk of developing substance use disorders later in life. This exploratory study aimed to understand patterns of nicotine use and perceptions of various nicotine products among adolescents and young adults (AYA) receiving medication treatment for opioid use disorder (MOUD). We administered an adapted version of the National Youth Tobacco Survey via REDCap to AYA (n=32) receiving outpatient care in the Medication-Assisted Treatment of Addiction at Nationwide Children's Hospital in Columbus, Ohio, U.S.A. Thirty (97%) participants had tried a combustible cigarette and 27 (90%) had tried an electronic cigarette. By age 13, nineteen (61%) participants had tried combustible cigarettes and eight (25%) had tried opioids. Twenty-two (71%) participants reported smoking combustible cigarettes every day for the past 30 days, and 15 (48%) reported smoking more than 10 cigarettes per day on average. Only ten (32%) participants reported e-cigarette use in the last 30 days. Participants universally agreed that tobacco products are dangerous, and twenty (67%) current tobacco users reported that they planned to quit in the next year. Nicotine use patterns among AYA receiving MOUD differ from that previously shown in the general population, primarily by high prevalence of nicotine use in early adolescence and high current combustible cigarette use. Interventions such as universal screening for nicotine use before age 13 and tailored smoking cessation programs for AYA with OUD may help optimize care for these individuals.</p>

opencc-zeroJul 2023View details →
ClinicalTrials.gov36/100

Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine

ClinicalTrials.gov study NCT04991974. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Clinical Decision Support for Opioid Use Disorders in Medical Settings (COMPUTE 2.0)

ClinicalTrials.gov study NCT04198428. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder

ClinicalTrials.gov study NCT04535583. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

SafetyNet Program for Opioid Use Disorder (OUD)

ClinicalTrials.gov study NCT04253782. IPD Sharing: NO. Countries: 1. Publications: 7.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.

ClinicalTrials.gov study NCT03212794. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Disclosure Intervention for People in Recovery From Opioid Use Disorder

ClinicalTrials.gov study NCT04836247. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine

ClinicalTrials.gov study NCT06784180. IPD Sharing: YES. Countries: 1. Publications: 20.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine

ClinicalTrials.gov study NCT04192370. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

ClinicalTrials.gov study NCT02672111. IPD Sharing: NO. Countries: 8. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

ClinicalTrials.gov study NCT03950492. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

ClinicalTrials.gov study NCT02537574. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Opioid Use Disorder in the Emergency Department: CTN 0069

ClinicalTrials.gov study NCT03023930. IPD Sharing: YES. Countries: 1. Publications: 6.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder

ClinicalTrials.gov study NCT04982029. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

ClinicalTrials.gov study NCT04199728. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

ClinicalTrials.gov study NCT04218201. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders

ClinicalTrials.gov study NCT04556552. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record